Pathological complete response in advanced gastric stromal tumor after imatinib mesylate therapy: a case report

INTRODUCTION: Gastrointestinal stromal tumors are a rare neoplasm exhibiting, in most cases, mutations of c-kit. Imatinib mesylate is the standard treatment for patients who have advanced gastrointestinal stromal tumors. Although the response rate in patients treated with imatinib mesylate in prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: El Mesbahi, Omar, Brahmi, Sami Aziz, Akasbi, Yousra, El Mrabet, Fatima Zahra, Touyar, Anas, Ossaden, Abdelmalek, Znati, Kaoutar, Maazaz, Khalid, Amarti, Affaf, Tizniti, Siham, Taleb, Khalid Ait, Ibrahimi, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124421/
https://www.ncbi.nlm.nih.gov/pubmed/21600007
http://dx.doi.org/10.1186/1752-1947-5-197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124421/
https://www.ncbi.nlm.nih.gov/pubmed/21600007
http://dx.doi.org/10.1186/1752-1947-5-197

Ejemplares similares